Abstract
Introduction
The role of laparoscopic TME for rectal cancer is still questioned as a safe and adequate cancer operation. Currently, multicenter randomized prospective trials are underway to evaluate this. We analyze our long-term results using laparoscopic TME in the treatment of rectal cancer to evaluate its oncologic outcomes.
Methods
A prospective laparoscopic database was queried to identify all patients operated upon for rectal cancer from April 1997 to September 2007. In total, 151 patients were identified. Metastatic disease excluded 19 patients, leaving 132 patients to be analyzed for perioperative and 5-year oncologic outcomes. Procedures included LAR, n = 35; transanal abdominal transanal proctosigmoidectomy, n = 77; and APR, n = 20. All surgeries were TME or pTME.
Results
Laparoscopic TME was performed on 89 men (67 %), mean age 61 (22–85). Preoperative chemoradiation was administered in 119 (90.2 %) with median dose of 5500 cGy (3800–10,080). Mean EBL was 300 ml, and 4.5 % were transfused. Seven patients (5.3 %) underwent conversion, 5 to lap-assisted, with a 1.5 % conversion rate to open. Pathologic stage of disease: complete response: 24 %; I: 36 %; II: 22 %; III: 18 %. There were no mortalities. Overall morbidity was 23.5 %, with no anastomotic leaks and 5 (3.8 %) delayed anastomotic stricture/fistula. There were no port site recurrences. Mean follow-up was 69.4 months (7.6–168.0). Overall LR was 5.3 % (n = 7). There was only one isolated LR (0.8 %). Mean time to local recurrence was 13.9 months. Metastatic rate was 18.2 %. By stage, disease-specific survival was: CR 86.3 %; I: 87.4 %; II: 86.4 %; III: 77.4 %. Overall, 5-year survival was 84.8 %.
Conclusion
The long-term data confirm that laparoscopic TME can be performed with lasting low local recurrence (5.3 %) and excellent 5-year survival (84.8 %). This report’s importance stems from it representing one of the largest experiences of rectal cancer treated by laparoscopic TME with greater than 5-year follow-up reported in the literature.
Similar content being viewed by others
References
Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg 69:613–616
Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482
Nogueras JJ (2012) Open low anterior resection. In: Wexner SD, Fleshman JW, Fischer JE (eds) Master techniques in general surgery: colon and rectal surgery: abdominal operations. Lippincott Williams & Wilkins, Philadelphia, pp 127–131
Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, Langmark F, Myrvold HE, Søreide O (2002) A national strategic change in treatment policy for rectal cancer—implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 45(7):857–866
Marijnen CA, Kapiteijn E, van de Velde CJ, Martijn H, Steup WH, Wiggers T, Kranenbarg EK, Leer JW (2002) Cooperative Investigators of the Dutch Colorectal Cancer Group. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 20(3):817–825
Kapiteijn E, Kranenbarg EK, Steup WH, Taat CW, Rutten HJ, Wiggers T, van Krieken JH, Hermans J, Leer JW, van de Velde CJ (1999) Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer: prospective randomised trial with standard operative and histopathological techniques: Dutch ColoRectal Cancer Group. Eur J Surg 165(5):410–420
Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ (2007) Dutch Colorectal Cancer Group. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246(5):693–701
The MRC Laparoscopic Groin Hernia Trial Group (1999) Laparoscopic versus open repair of groin hernia: a randomised comparison. The Lancet 354(9174):185–190
Stauffer JA, Rosales-Velderrain A, Goldberg RF, Bowers SP, Asbun HJ (2013) Comparison of open with laparoscopic distal pancreatectomy: a single institution’s transition over a 7-year period. HPB 15(2):149–155
The Clinical Outcomes of Surgical Therapy Study Group (2004) A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 350:2050–2059
Fleishman J, Sargent DJ, Green E et al (2007) Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST study group trial. Ann Surg 246:655–664
Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ, Haglind E, Påhlman L, Cuesta MA, Msika S, Morino M, Lacy AM (2005) COlon cancer Laparoscopic or Open Resection Study Group (COLOR). Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 6(7):477–484
Lacy AM, Delgado S, Castells A, Prins HA, Arroyo V, Ibarzabal A, Pique JM (2008) The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann Surg 248(1):1–7
Lacy AM, García-Valdecasas JC, Piqué JM, Delgado S, Campo E, Bordas JM, Taurá P, Grande L, Fuster J, Pacheco JL et al (1995) Short-term outcome analysis of a randomized study comparing laparoscopic vs open colectomy for colon cancer. Surg Endosc 9(10):1101–1105
Tekkis PP, Senagore AJ, Delaney CP, Fazio VW (2005) Evaluation of the learning curve in laparoscopic colorectal surgery: comparison of right-sided and left-sided resections. Ann Surg 242:83–91
Wexner SD, Cohen SM, Ulrich A, Reissman P (1995) Laparoscopic colorectal surgery—Are we being honest with our patients? Dis Colon Rectum 38(7):723–727
Künzli BM, Friess H, Shrikhande SV (2010) Is laparoscopic colorectal cancer surgery equal to open surgery? An evidence based perspective. World J Gastrointest Surg 2(4):101–108
Bretagnol F, Lelong B, Laurent C, Moutardier V, Rullier A, Monges G, Delpero JR, Rullier E (2005) The oncological safety of laparoscopic total mesorectal excision with sphincter preservation for rectal carcinoma. Surg Endosc 19(7):892–896
Laurent C, Leblanc F, Gineste C, Saric J, Rullier E (2007) Laparoscopic approach in surgical treatment of rectal cancer. Br J Surg 94(12):1555–1561
Leroy J, Jamali F, Forbes L, Smith M, Rubino F, Mutter D, Marescaux J (2004) Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes. Surg Endosc 18(2):281–289
Arezzo A, Passera R, Scozzari G, Verra M, Morino M (2013) Laparoscopy for rectal cancer reduces short-term mortality and morbidity: results of a systematic review and meta-analysis. Surg Endosc 27(5):1485–1502
Gong J, Shi DB, Li XX, Cai SJ, Guan ZQ, Xu Y (2012) Short-term outcomes of laparoscopic total mesorectal excision compared to open surgery. World J Gastroenterol 18(48):7308–7313
Ying X, Li Z, Shen Y, Ye P, Pan W, Chen H, Zhang L (2013) Total mesorectal excision for rectal cancer: laparoscopic versus open approach. Tumori 99(2):154–158
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM et al (2005) MRC CLASICC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASSICC trial): multicentre, randomized controlled trial. Lancet 365:1718–1726
Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM et al (2007) UK MRC CLASICC Trial Group. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25:3061–3068
Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ (2010) Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 97:1638–1645
Fleshman J. American College of Surgeons Oncology Group (ACOSOG)-Z6051. A phase III prospective randomized trial comparing laparoscopic-assisted resection versus open resection for rectal cancer. http://clinicaltrials.gov/ct2/show/NCT00726622. Accessed 15 Nov 2014
Color II Study Group, Buunen M, Bonjer HJ, Hop WC, Haglind E, Kurlberg G, Rosenberg J, Lacy AM, Cuesta MA, D’Hoore A, Fürst A, Lange JF, Jess P, Bulut O, Poornoroozy P, Jensen KJ, Christensen MM, Lundhus E, Ovesen H, Birch D, Iesalnieks I, Jäger C, Kreis M, Van riet Y, Van der Harst E, Gerhards MF, Bemelman WA, Hansson BM, Neijenhuis PA, Prins HA, Balague C, Targarona E, Luján Mompeán JA, Franco Osorio JD, Garcia Molina FJ, Skullman S, Läckberg Z, Kressner U, Matthiessen P, Kim SH, Poza AA (2009) COLOR II: a randomized clinical trial comparing laparoscopic and open surgery for rectal cancer. Dan Med Bull 56(2):89–91
Kim NK, Kang J (2010) Optimal total mesorectal excision for rectal cancer: the Role of robotic surgery from an expert’s view. J Korean Soc Coloproctol 26(6):377–387
Marks G, Mohiuddin M, Goldstein SD (1988) Sphincter preservation for cancer of the distal rectum using high dose preoperative radiation. Int J Radiat Oncol Biol Phys 15(5):1065–1068
Mohiuddin M, Marks G (1991) High dose preoperative irradiation for cancer of the rectum, 1976–1988. Int J Radiat Oncol Biol Phys 20(1):37–43
Murty M, Enker WE, Martz J (2000) Current status of total mesorectal excision and autonomic nerve preservation in rectal cancer. Semin Surg Oncol 19:321–328
Enker WE, Thaler HT, Cranor ML, Polyak T (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335–346
Lacy AM, Garcia-Valdescasas JC, Delgado S et al (2002) Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomized trial. Lancet 359(9325):2224–2229
Morino M, Parini U, Giraudo G, Salval M, Brachet Contul R, Carrone C (2003) Laparoscopic total mesorectal excision: a consecutive series of 100 patients. Ann Surg 237:335–342
Laurent C, Leblanc F, Wütrich P, Scheffler M, Rullier E (2009) Laparoscopic versus open surgery for rectal cancer: long-term oncologic results. Ann Surg 250(1):54–61
Green BL, Marshall HC, Collinson F, Quirke P, Guillou P, Jayne DG, Brown JM (2013) Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg 700:75–82
Disclosures
Drs. John H Marks and Renee Huang, Ms. McKeever, and Ms. Greenfield have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marks, J.H., Huang, R., McKeever, D. et al. Outcomes in 132 patients following laparoscopic total mesorectal excision (TME) for rectal cancer with greater than 5-year follow-up. Surg Endosc 30, 307–314 (2016). https://doi.org/10.1007/s00464-015-4210-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-015-4210-1